medigraphic.com
SPANISH

16 de abril

ISSN 1729-6935 (Electronic)
16 de abril
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
  • ABOUT US
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 280

<< Back Next >>

16 de abril 2021; 60 (280)

Relationship between pulmonary embolism and stroke

Riverón-Carralero WJ, Góngora-Gómez O
Full text How to cite this article

Language: Spanish
References: 5
Page: 1-2
PDF size: 314.25 Kb.


Key words:

No keywords

Text Extraction

Cerebrovascular disease is any alteration, transitory or permanent, of one or more brain areas, as a consequence of a cerebral circulation disorder . It can be classified as ischemic, due to the interruption of the blood supply, or hemorrhagic due to the rupture of a cerebral vessel.
Linked in direct proportion to hospital mortality, the frequent, numerous and above all foreseeable clinical systemic and neurological complications of the acute phase, those that generate death or neurological disability, are associated with the mass effect and the extent of the lesion. and they represent a potential barrier to the optimal recovery of the patient.
Optimizing urgent diagnostic strategies to reduce the time from the onset of stroke to therapeutic medical action, as well as providing specific treatment adapted to each subtype of stroke, etiology, location and size, and starting secondary prevention are key determinants to improve the prognosis of the ill person.


REFERENCES

  1. Irimia P, Esparragosa I, ValentíR, Martínez – Vila E. Enfermedadescerebrovasculares. Hemorragia Cerebral.Medicine [Internet]. 2020 [citado12 de Mar de 2020]; 12 (70): 4075-84. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0026-17422012000300003&lng=es

  2. García PJ, García AP, Santana J.Índice leuco glucémico como predictora corto plazo de mortalidad en el ictusisquémico. Rev. Arch Med Camagüey2018 [citado 10 de Mar de 2020]; 22(2): aprox. 7p. Disponible en: http://revistaamc.sld.cu/index.php/amc/article/view/5445/3084

  3. Martinez C, Cohen A, Bamber L,Rietbrock S. Epidemiology of first and recurrentvenous thromboembolism: A populationbased cohort study in patientswithout active cancer. Thromb Haemost.2014 [citado 28 de Feb de 2020]; 112(2): 255-63. Disponible en: http://refhub.elsevier.com/S0014-2565(17)30098-X/sbref0395

  4. Eswaradass PV, Dey S, Singh D,Hill MD. Pulmonary Embolism in IschemicStroke. Canadian Journal of NeurologicalSciences Inc. 2018 [citado 18 defeb de 2020]. Disponible en: https://doi.org/10.1017/cjn.2017.288

  5. Pongmoragot J, RabinsteisAA, Nilanont Y, Swartz RH, Zhou L, SaposnikG, et al. Pulmonary Embolismin Ischemic Stroke: Clinical Presentation,Risk Factors, and Outcome. JAHA2013 [citado 04 de Mar de 2020]; 2 (6):Aprox 8p. Disponible en: https://www.ahajournals.org/doi/epub/10.1161/JAHA.113.000372




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

16 de abril. 2021;60